普拉西斯精准医疗
PRAX
241.76
-6.48
-2.61%
普拉西斯精准医疗
US · PRAX
#1645 按市值排名
上市于 2020
241.76
-6.48
-2.61%
实时 - 追踪5344个代码 - 心跳于398秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
增持
- 机构持股总比例上升了0.2个百分点。
机构持股
- 机构持股比例
- 122.52% +0.19pp
- 机构数量
- 377
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期增持了股份,同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund78.93%
Hedge Fund23.46%
VC/PE Fund9.45%
Public Company6.82%
Government Pension Fund1.35%
Sovereign Wealth Fund1.25%
Private Company1.04%
Individual/Insider0.19%
Insurance Company0.18%
主要股东 截至 2026-06-30
Janus Henderson Group plc
12.25% · 3.42M 股
FMR
8.29% · 2.32M 股
BlackRock
8.21% · 2.29M 股
Perceptive Advisors LLC
7.29% · 2.04M 股
Baker Bros. Advisors LP
6.28% · 1.75M 股
Orbis Investment Management Limited
5.48% · 1.53M 股
Vanguard Capital Management, LLC
5.10% · 1.42M 股
Vanguard Portfolio Management, LLC
4.78% · 1.34M 股
T. Rowe Price Group, Inc.
3.95% · 1.10M 股
State Street Global Advisors
3.68% · 1.03M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 35次买入 · 15次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Dean Mitchell | Independent Chairperson | 0.06% |
| Timothy Kelly | Chief Financial Officer | 0.03% |
| Alex Nemiroff | General Counsel | 0.02% |
| Megan Sniecinski | Chief Business Officer | 0.02% |
| Lauren Mastrocola | VP of Finance & Principal Accounting Officer | 0.01% |
| Jill DeSimone | Independent Director | 0.01% |
| William Young | Independent Director | 0.01% |
| Marcio De'Souza | Chief Executive Officer | 0.00% |
| Jeffrey Kindler | Director | 0.00% |
| Stuart Arbuckle | Director | 0.00% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-07-07 | Marcio De'Souza | Chief Executive Officer | Other Disposition | -23,121 | -- |
| 2026-06-23 | Jill DeSimone | Independent Director | Derivative Exercise and Sale | -11,600 | $44.25–315.71 |
| 2026-06-09 | William Young | Independent Director | Other Acquisition | +1,371 | -- |
| 2026-06-09 | William Young | Independent Director | Other Derivative Acquisition | +648 | $240.66 |
| 2026-06-09 | Jeffrey Kindler | Director | Other Acquisition | +1,371 | -- |
| 2026-06-09 | Jeffrey Kindler | Director | Other Derivative Acquisition | +648 | $240.66 |
| 2026-06-09 | Dean Mitchell | Independent Chairperson | Other Acquisition | +1,371 | -- |
| 2026-06-09 | Dean Mitchell | Independent Chairperson | Other Derivative Acquisition | +648 | $240.66 |
| 2026-06-09 | Gregory Norden | Independent Director | Other Acquisition | +1,371 | -- |
| 2026-06-09 | Gregory Norden | Independent Director | Other Derivative Acquisition | +648 | $240.66 |
| 2026-06-09 | Merit Cudkowicz | Independent Director | Other Acquisition | +1,371 | -- |
| 2026-06-09 | Merit Cudkowicz | Independent Director | Other Derivative Acquisition | +648 | $240.66 |
| 2026-06-09 | Stuart Arbuckle | Director | Other Acquisition | +1,371 | -- |
| 2026-06-09 | Stuart Arbuckle | Director | Other Derivative Acquisition | +648 | $240.66 |
| 2026-06-09 | Jill DeSimone | Independent Director | Other Acquisition | +1,371 | -- |
| 2026-06-09 | Jill DeSimone | Independent Director | Other Derivative Acquisition | +648 | $240.66 |
| 2026-06-09 | Jeffrey Chodakewitz | Independent Director | Other Acquisition | +1,371 | -- |
| 2026-06-09 | Jeffrey Chodakewitz | Independent Director | Other Derivative Acquisition | +648 | $240.66 |
| 2026-05-13 | Alex Nemiroff | General Counsel | Other Acquisition | +78 | $167.94 |
| 2026-05-13 | Marcio De'Souza | Chief Executive Officer | Other Acquisition | +126 | $167.94 |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:32 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
普拉西斯精准医疗 讨论区 0 条评论